Free Trial

Lifecore Biomedical Q1 2025 Earnings Report

Lifecore Biomedical logo
$6.90 -0.14 (-1.92%)
As of 10:30 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Lifecore Biomedical EPS Results

Actual EPS
-$0.53
Consensus EPS
-$0.46
Beat/Miss
Missed by -$0.07
One Year Ago EPS
N/A

Lifecore Biomedical Revenue Results

Actual Revenue
$24.71 million
Expected Revenue
$23.30 million
Beat/Miss
Beat by +$1.41 million
YoY Revenue Growth
N/A

Lifecore Biomedical Announcement Details

Quarter
Q1 2025
Time
N/A

LFCR Upcoming Earnings

Lifecore Biomedical will be holding an earnings conference call on Thursday, April 3 at 4:30 PM Eastern. Interested parties can register for or listen to the call.

Conference Call Resources

Remove Ads

Lifecore Biomedical Earnings Headlines

Craig-Hallum Keeps Their Buy Rating on Lifecore Biomedical (LFCR)
Elon Set to Shock the World by May 1st ?
Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believes will be Elon’s greatest invention ever… Yes, even bigger than Tesla or SpaceX.
See More Lifecore Biomedical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Lifecore Biomedical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Lifecore Biomedical and other key companies, straight to your email.

About Lifecore Biomedical

Lifecore Biomedical (NASDAQ:LFCR), together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States and internationally. The company engages in the manufacturing of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.

View Lifecore Biomedical Profile

More Earnings Resources from MarketBeat